OM

$3.61

Post-MarketAs of Mar 17, 8:00 PM UTC

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$3.61
Potential Upside
5%
Whystock Fair Value$3.79
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-de...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$66.10M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.10
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-106.20%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
5.24

Recent News

Insider Monkey
Feb 20, 2026

Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results

Outset Medical, Inc. (NASDAQ:OM) is one of the 7 most volatile stocks under $5 for day trading. On February 12, 2026, Outset Medical, Inc. (NASDAQ:OM) shares received fresh support from analysts despite a decline in price targets after fourth-quarter results that largely met expectations. After the company provided what it considered to be a realistic […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 14, 2026

US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results

There's been a major selloff in Outset Medical, Inc. ( NASDAQ:OM ) shares in the week since it released its annual...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Feb 12, 2026

Outset Medical, Inc. Q4 2025 Earnings Call Summary

Moby summary of Outset Medical, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Feb 12, 2026

Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial ...

Outset Medical Inc (OM) reports FDA clearance for its NextGen Tableau, revenue growth, and improved gross margins, despite challenges in product revenue and sales cycles.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Feb 11, 2026

Outset Medical Q4 Earnings Call Highlights

Outset Medical (NASDAQ:OM) highlighted a year of operational progress, continued gross margin expansion, and an upcoming product launch during its fourth-quarter 2025 earnings call, as management emphasized cost reductions alongside investments aimed at extending the company’s technology and service

BEARISH
Negative press. News cycle fixated on risk factors or misses.